Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Notice of NEI Participation in PAR-27-077 NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)

Active
NOT-EY-27-004Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Eye Institute is announcing its participation in the NIH Science Education Partnership Award (SEPA), identified as PAR-27-077. This participation is effective for all applications with due dates on or after January 25, 2027. The funding opportunity is designated as an R25 grant, and clinical trials are not allowed. The NEI joins a broad group of participating NIH organizations, including the National Institute of General Medical Sciences and the National Institute on Aging, among others. All applications must align with the mission of the participating Institutes or Centers. The update specifically adds the National Eye Institute to the list of participating organizations and provides the corresponding scientific and financial grants management contacts for the agency.

General Info

NEI joins NIH SEPA R25 grant funding for applications due after January 25, 2027.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

Contract opportunity posted

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes Of Health → National Eye Institute
Contacts22 people available
OfficeUSA
Office AddressUSA
Contacts
National Human Genome Research Institute (NHGRI
Office of Research Training and Career Development
National Center for Complementary and Integrative Health (NCCIH
National Institute of Allergy and Infectious Diseases (NIAIDScientific/Research Contact:
Office of Research on Women's Health (ORWH
National Institute on Aging (NIA
Division of Interdisciplinary TrainingNational Instituter of Biomedical Imaging and Bioengineering (NIBIB)
ODSS - Office of Data Science Strategy
National Institute on Minority Health and Health Disparities (NIMHD
National Institute of Dental and Craniofacial Research (NIDCR
NIGMS PPBC GAB NOFO
National Human Genome Research Institute (NHGRI
Chief Grants Management Officer
National Institute of Allergy and Infectious Diseases (NIAIDFinancial/Grants Management Contact:
National Institute on Aging (NIA
Chief Grants Management Officer
National Institute on Minority Health and Health Disparities (NIMHD
National Institute of Dental and Craniofacial Research (NIDCR
National Eye Institute (NEI

Full Description

Show more
This Notice informs potential applicants that the National Eye Institute ( NEI) is participating, effective for application due dates on or after January 25, 2027, in PAR-27-077 NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Currently Reads Part 1. Overview Information Components of Participating Organizations National Institute of General Medical Sciences ( NIGMS) National Human Genome Research Institute ( NHGRI) National Institute on Aging ( NIA) National Institute of Allergy and Infectious Diseases ( NIAID) National Institute of Biomedical Imaging and Bioengineering ( NIBIB) National Institute of Dental and Craniofacial Research ( NIDCR) National Institute on Drug Abuse ( NIDA) National Institute of Mental Health ( NIMH) National Institute on Minority Health and Health Disparities ( NIMHD) National Center for Complementary and Integrative Health ( NCCIH) All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers. Office of Research on Women's Health ( ORWH) Office of Data Science Strategy ( ODSS) Assistance Listing Number(s) 93.859, 93.121, 93.213, 93.313, 93.855, 93.242, 93.286, 93.279, 93.172, 93.866, 93.307, 93.310 Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) NIGMS SEPA National Institute of General Medical Sciences (NIGMS) National Human Genome Research Institute (NHGRI) Scientific Program Contact: Office of Research Training and Career Development National Institute on Drug Abuse (NIDA) National Center for Complementary and Integrative Health (NCCIH) NIMH Scientific contact: National Institute of Allergy and Infectious Diseases (NIAID) Scientific/Research Contact: Office of Research on Women's Health (ORWH) National Institute on Aging (NIA) Division of Interdisciplinary Training National Instituter of Biomedical Imaging and Bioengineering (NIBIB) NIBIB Research Education ODSS - Office of Data Science Strategy National Institute on Minority Health and Health Disparities (NIMHD) National Institute of Dental and Craniofacial Research ( NIDCR) Scientific Contact: Financial/Grants Management Contact(s) NIGMS PPBC GAB NOFO National Institute of General Medical Sciences (NIGMS) National Human Genome Research Institute (NHGRI) Grants Administration Branch Chief, Grants Management Officer National Institute of Drug Abuse (NIDA) National Center for Complementary and Integrative Health (NCCIH) NIMH Grants management contact: National Institute of Allergy and Infectious Diseases (NIAID) Financial/Grants Management Contact: National Institute on Aging (NIA) Chief Grants Management Officer National Institute of Biomedical Imaging and Bioengineering (NIBIB) National Institute on Minority Health and Health Disparities (NIMHD) National Institute of Dental and Craniofacial Research ( NIDCR) Grants Management: Revised to Read The following text (shown in bold italics) has been added to reflect NEI's participation in this NOFO: Part 1. Overview Information Components of Participating Organizations National Eye Institute ( NEI) Assistance Listing Number(s) 93.867 Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) National Eye Institute ( NEI) NEI Extramural Programs Financial/Grants Management Contact(s) National Eye Institute ( NEI) NEI Grants Management All other aspects of the NOFO remain the same.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
FY 26 Broad Agency Announcement (BAA) - Federal Railroad Administration
Solicitation # 693JJ626R000001
The Federal Railroad Administration Office of Research, Development, and Technology is soliciting applied research projects through the FY 2026 Broad Agency Announcement 693JJ626R000001 to support rail safety and efficiency. The scope of work focuses on three primary research divisions: Track, Rolling Stock and Equipment, and Train Control and Communications. Interested innovators and subject matter experts must submit concept papers for review, which, if approved, allow for the submission of a full proposal. The solicitation operates on a rolling basis with a final deadline of September 30, 2027, though specific research topics are periodically removed via amendments as they become unavailable. Awards may be structured as firm-fixed-price or cost-reimbursable contracts, with technical merit serving as the most significant evaluation factor, followed by cost or price and past performance. Selected contractors are required to provide detailed statements of work, annual research results or technical reports, and periodic self-assessments. Contract administration is managed through the DELPHI system for electronic invoicing, and all deliverables must be submitted 30 days prior to the end of the performance period. Compliance requirements include adherence to FAR clauses regarding telecommunications equipment, patent rights reporting via DD Form 882, and strict reporting templates for monthly and quarterly progress.
Federal Railroad Administration

POSTED

1 day ago

DEADLINE

in 11 months
View Details
NAICS: 541715
New
Federal
Protein Palace Proposers Day
Solicitation # DARPA-SN-27-01
The Defense Advanced Research Projects Agency (DARPA) Multi X Office is hosting an in-person Proposers Day for the Protein Palace program on November 17, 2026, at the Executive Conference Center in Arlington, Virginia. This event is issued under Special Notice DARPA-SN-27-01 for information and program planning purposes and does not constitute a formal solicitation. The Protein Palace program seeks to develop agile, tunable protein purification methods that move beyond current state-of-the-art physicochemical methods to separate target proteins at high purity and yield. The program is structured in two phases: a 24-month first phase focusing on specificity and generalizability by separating eight different proteins, followed by an 18-month second phase focusing on scalability and throughput using two difficult-to-purify proteins. Interested parties must register by November 9, 2026, at 4:00 p.m. ET, submitting required documentation such as DARPA Form 104, Form 60 for permanent residents or foreign nationals, or a Foreign Visit Request for official foreign government personnel. The event will be held at the unclassified level, and attendees must provide government-issued photo identification. While a formal solicitation is expected to be released on sam.gov prior to the event, any proposals submitted in response to this special notice will be disregarded. Technical inquiries are directed to Dr. Huanan Zhang, the MXO Program Manager.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
STAR-FISH CALL 017 - Secure By Design
Solicitation # FA945326XA001
The Air Force Research Laboratory, Space Vehicles Directorate, is soliciting white papers under CALL 017 of the Space Technology Advanced Research - Fast-tracking Innovative Software and Hardware (STAR-FISH) program. This effort, titled Secure by Design Space Vehicle (SDSV), aims to mitigate cyber threats to critical national space missions, including SATCOM, ISR, PNT, and Missile Warning/Tracking. The objective is to research, design, and demonstrate a cyber-hardened space vehicle system that reduces attack surfaces and implements resiliency mechanisms for self-protection and rapid recovery. The scope of work includes the construction of a space vehicle flat-sat and cyber range, the integration of Cyber-Hardened Satellite Software (CHSS), and a progression from ground-based experimentation to a live on-orbit demonstration. This is a two-step procurement process starting with the submission of unclassified white papers and rough order of magnitude cost estimates, due by 1600 MST on November 13, 2026, via DoD Safe. Selected offerors will then be invited to submit full proposals. The government anticipates awarding multiple Cost Plus Fixed Fee (CPFF) contracts with a total estimated value of 14 million dollars, distributed across fiscal years 2027 through 2030. The period of performance extends from October 12, 2026, to October 11, 2031. Evaluation will be conducted through a peer or scientific review process using a weight of scientific evidence approach, prioritizing technical merit and relevance to DOD missions over cost realism. Offerors must be US citizens, maintain valid SAM registration, and provide a detailed Organizational Conflict of Interest analysis. Security requirements range from CUI to Secret, and any deliverable items with a unit acquisition cost of 5,000 dollars or more will require unique item identification. All payment requests must be processed electronically through the Wide Area Work Flow system.
FA9453 Afrl Rjz

POSTED

1 day ago

DEADLINE

in 21 days
View Details

More opportunities from National Institutes Of Health → National Eye Institute

Same awarding agency

NAICS: 541714
Grant
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Solicitation # PAR-28-072
The National Eye Institute's Translational Research Program (TRP) aims to accelerate the transition of laboratory research into clinical therapeutics for visual system diseases. This program supports the development of pharmaceutical, biological, medical device, or combination therapies through a bi-phasic, milestone-driven award structure. All projects begin with an R61 phase for up to two years to support research with significant preliminary data. Successful projects may transition to an R33 phase for up to four years, focusing on final preclinical development, filing IND/IDE packages with the FDA, and designing future clinical trials. The combined duration of both phases cannot exceed five years. A critical requirement of this program is the establishment of SMART milestones for both phases, which must be specific, measurable, achievable, relevant, and time-bound. Applicants are encouraged to provide contingency plans to address potential delays in meeting these goals. The ultimate objective of the R33 phase is for recipients to either obtain an IND/IDE application or transition the product into clinical practice within the performance period. This solicitation, identified as PAR-28-072, is issued by the National Institutes of Health.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

29 days ago

DEADLINE

in about 3 years
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS